EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Refining the risk stratification in advanced‐stage classical Hodgkin lymphoma: A critical analysis of clinical prediction models

Oguzhan Koca iD, Ahmet Emre Eskazan iD

British Journal of Haematology · 2025-11 · 207 (5) · 1744-1754

DOI: 10.1111/bjh.70115 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 22.08.2025. Verfasst von Oguzhan Koca und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Hodgkin Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Classical Hodgkin lymphoma (cHL) is a haematological malignancy with high curability; however, prognosis varies significantly based on clinical and biological factors. To enhance risk stratification, several clinical prediction models have been developed over time, particularly for advanced‐stage cHL. The International Prognostic Score (IPS), introduced in 1998, was the first widely adopted model, later refined in 2012 (updated IPS) and further simplified in 2015 (IPS‐3). Despite their prognostic utility, these models have demonstrated declining predictive performance due to advancements in cHL treatment. In response, the HoLISTIC consortium recently introduced the Advanced‐Stage Hodgkin Lymphoma International Prognostic Index (A‐HIPI) in 2023. Unlike previous models, A‐HIPI incorporates continuous variables, aiming to provide a more precise risk assessment. However, its applicability to older patients remains uncertain, necessitating further validation studies. Additionally, none of the existing models incorporate dynamic treatment response markers such as interim positron emission tomography/computed tomography (PET/CT), which have shown strong prognostic value. This review comprehensively discusses the evolution, strengths and limitations of these prediction models, their clinical implications and the necessity for future refinements integrating dynamic biomarkers and treatment response indicators. The integration of machine learning and multi‐omics approaches could further enhance risk stratification, improve treatment personalization and optimize patient outcomes in cHL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseHumansRisk AssessmentPrognosisNeoplasm StagingPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

A‐HIPIHodgkin lymphomaIPSprediction modelprognosis

Autor:innen und Institutionen

  • Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, UK.
  • Division of Hematology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

ORCID-Profile: Oguzhan Koca, Ahmet Emre Eskazan

Zitieren

APA

Koca, O., & Eskazan, A. E. (2025). Refining the risk stratification in advanced‐stage classical Hodgkin lymphoma: A critical analysis of clinical prediction models. British Journal of Haematology, 207(5), 1744-1754. https://doi.org/10.1111/bjh.70115

Vancouver

Koca O, Eskazan AE. Refining the risk stratification in advanced‐stage classical Hodgkin lymphoma: A critical analysis of clinical prediction models. British Journal of Haematology. 2025;207(5):1744-1754. doi:10.1111/bjh.70115

BibTeX
@article{Koca2025,
  author = {Koca, Oguzhan and Eskazan, Ahmet Emre},
  title = {Refining the risk stratification in advanced‐stage classical Hodgkin lymphoma: A critical analysis of clinical prediction models},
  journal = {British Journal of Haematology},
  year = {2025},
  volume = {207},
  number = {5},
  pages = {1744--1754},
  doi = {10.1111/bjh.70115}
}
Kostenlos starten →